Assay And Drug Development Technologies

Journal Title：Assay And Drug Development Technologies

ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application.

ASSAY and Drug Development Technologies coverage includes:

-Assay design, target development, and high-throughput technologies-

Hit to Lead optimization and medicinal chemistry through preclinical candidate selection-

Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis-

Approaches to assays configured for gene families, inherited, and infectious diseases-

Assays and strategies for adapting model organisms to drug discovery-

The use of stem cells as models of disease-

Translation of phenotypic outputs to target identification-

Exploration and mechanistic studies of the technical basis for assay and screening artifacts

《分析和药物开发技术》提供了新技术和强大工具，可实现早期筛选的关键进展。本期刊上发表的这项研究为药物发现和开发提供了重要的治疗方法和平台。这本享有盛誉的同行评审期刊刊登原创论文、应用型技术评论、新兴研究领域的专题以及方法和技术应用报告。

分析和药物开发技术报道包括：

-分析设计、靶标开发和高通量技术-

通过临床前候选药物选择实现先导化合物优化和药物化学-

实验室自动化、样品管理、生物信息学、数据挖掘、虚拟筛选和数据分析-

针对基因家族、遗传和传染病配置的分析方法-

使模型生物适应药物发现的分析和策略-

使用干细胞作为疾病模型-

将表型输出转化为靶标识别-

分析和筛选制品的技术基础探索和机制研究

Assay And Drug Development Technologies创刊于2002年，由Mary Ann Liebert Inc.出版商出版，收稿方向涵盖生化研究方法 - 医学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度 12周，或约稿 ，影响因子指数1.6，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。